New York, USA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The TGF-β ...
In patients, non-proliferative disseminated tumour cells (DTCs) can persist in the bone marrow (BM) while other organs (such as lung) present growing metastasis. This suggested that the BM might be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback